🇺🇸 FDA
Pipeline program

Hydrocortisone

DIUR-006

Phase 3 small_molecule completed

Quick answer

Hydrocortisone for Congenital Adrenal Hyperplasia is a Phase 3 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 2 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Congenital Adrenal Hyperplasia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials